肝细胞癌的成功靶向治疗：我们真的做到了吗？ - Suppr

Suppr

超能文献

Successful targeted therapies for hepatocellular carcinoma: are we really getting there?

作者信息

Zhu Andrew X

出版信息

Expert Rev Anticancer Ther. 2008 Apr;8(4):499-505. doi: 10.1586/14737140.8.4.499.

DOI:10.1586/14737140.8.4.499

PMID:18402516

Abstract

摘要

相似文献

Successful targeted therapies for hepatocellular carcinoma: are we really getting there?

Expert Rev Anticancer Ther. 2008 Apr;8(4):499-505. doi: 10.1586/14737140.8.4.499.

[Targeted HCC therapies: the door has been opened!].

Gastroenterol Clin Biol. 2008 Jan;32(1 Pt. 1):1-2. doi: 10.1016/j.gcb.2007.12.001. Epub 2008 Mar 4.

[An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].

Zentralbl Chir. 2009 Jun;134(3):189-92. doi: 10.1055/s-0029-1224838. Epub 2009 Jun 18.

[Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations].

Gastroenterol Clin Biol. 2008 Jan;32(1 Pt. 1):3-7. doi: 10.1016/j.gcb.2007.11.001. Epub 2008 Mar 4.

Targeted therapy of hepatocellular cancer.

Expert Opin Investig Drugs. 2010 Feb;19(2):265-74. doi: 10.1517/13543780903514110.

Targeting vessels to treat hepatocellular carcinoma.

Clin Sci (Lond). 2008 Apr;114(7):467-77. doi: 10.1042/CS20070310.

From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.

Oncology. 2007;72 Suppl 1:30-44. doi: 10.1159/000111705. Epub 2007 Dec 13.

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.

Expert Opin Pharmacother. 2010 Sep;11(13):2187-98. doi: 10.1517/14656561003724705.

Latest developments in targeted therapy for hepatocellular carcinoma.

Expert Rev Anticancer Ther. 2010 Oct;10(10):1635-46. doi: 10.1586/era.10.146.

Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma.

Gan To Kagaku Ryoho. 2010 Oct;37(10):1883-86.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Successful targeted therapies for hepatocellular carcinoma: are we really getting there?

Expert Rev Anticancer Ther. 2008 Apr;8(4):499-505. doi: 10.1586/14737140.8.4.499.

[Targeted HCC therapies: the door has been opened!].

Gastroenterol Clin Biol. 2008 Jan;32(1 Pt. 1):1-2. doi: 10.1016/j.gcb.2007.12.001. Epub 2008 Mar 4.

[An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].

Zentralbl Chir. 2009 Jun;134(3):189-92. doi: 10.1055/s-0029-1224838. Epub 2009 Jun 18.

[Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations].

Gastroenterol Clin Biol. 2008 Jan;32(1 Pt. 1):3-7. doi: 10.1016/j.gcb.2007.11.001. Epub 2008 Mar 4.

Targeted therapy of hepatocellular cancer.

Expert Opin Investig Drugs. 2010 Feb;19(2):265-74. doi: 10.1517/13543780903514110.

Targeting vessels to treat hepatocellular carcinoma.

Clin Sci (Lond). 2008 Apr;114(7):467-77. doi: 10.1042/CS20070310.

From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.

Oncology. 2007;72 Suppl 1:30-44. doi: 10.1159/000111705. Epub 2007 Dec 13.

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.

Expert Opin Pharmacother. 2010 Sep;11(13):2187-98. doi: 10.1517/14656561003724705.

Latest developments in targeted therapy for hepatocellular carcinoma.

Expert Rev Anticancer Ther. 2010 Oct;10(10):1635-46. doi: 10.1586/era.10.146.

Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma.

Gan To Kagaku Ryoho. 2010 Oct;37(10):1883-86.